Protalix BioTherapeutics, Inc. (PLX) has 20 known insider and institutional holders on record. The largest holder is Sheratzki Eyal with 14,466,319 shares. Other notable holders include Camber Capital Management LLC and FROST PHILLIP MD ET AL.
Over the last 12 months, insiders have made 14 transactions in PLX stock — 11 buys (valued at $946.84K) and 1 sells (valued at $314.16). Insider buying has outpaced selling during this period, which may signal confidence in the company's prospects.
PLX Insider Ownership
Top Holder
Sheratzki Eyal
14,466,319 shares
Buys (12 mo)
11
$946.84K value
Sells (12 mo)
1
$314.16 value
12-Month Transaction Activity
Top Insider Holders
| # |
Name |
Role |
Shares Owned |
Last Filed |
Relative Size |
| 1 |
Sheratzki Eyal |
10 Percent Owner |
14,466,319 |
2007-01-05 |
|
| 2 |
Camber Capital Management Llc |
10 Percent Owner |
10,775,000 |
2016-12-06 |
|
| 3 |
Frost Phillip Md Et Al |
10 Percent Owner |
7,738,241 |
2009-09-11 |
|
| 4 |
Marathon Investments Ltd. |
10 Percent Owner |
6,556,381 |
2007-01-10 |
|
| 5 |
Toussia-cohen Sharon |
10 Percent Owner |
6,556,381 |
2007-01-05 |
|
| 6 |
Techno-rov Holdings (1993) Ltd |
10 Percent Owner |
6,186,046 |
2007-01-05 |
|
| 7 |
Akirov Alfred |
Director |
4,917,713 |
2013-08-16 |
|
| 8 |
Dexcel Pharma Technologies Ltd. |
10 Percent Owner |
4,494,820 |
2021-06-03 |
|
| 9 |
Hurvitz Eli |
Director |
1,616,100 |
2007-01-05 |
|
| 10 |
Bio-cell Ltd |
10 Percent Owner |
1,509,948 |
2014-09-18 |
|
| 11 |
Manor Moshe |
President & CEO |
1,300,000 |
2018-09-14 |
|
| 12 |
Maimon Yossi |
VP, Chief Financial Officer |
700,000 |
2018-09-14 |
|
| 13 |
Shaaltiel Yoseph |
Executive VP, R&d |
700,000 |
2018-09-14 |
|
| 14 |
Rubin Eyal |
Sr. VP and CFO |
660,909 |
2024-11-05 |
|
| 15 |
Aviezer David |
President & CEO |
418,000 |
2012-07-18 |
|
| 16 |
Katz Iftah |
VP of Operations |
204,351 |
2007-06-13 |
|
| 17 |
Almon Einat Brill |
SVP, Chief Development Officer |
196,995 |
2020-06-08 |
|
| 18 |
Bashan Dror |
President and CEO |
188,516 |
2025-12-23 |
|
| 19 |
Yanai Shlomo |
Director |
150,000 |
2014-07-24 |
|
| 20 |
Palash Tzvi |
Chief Operating Officer |
125,000 |
2015-05-07 |
|
Recent Transactions (last 12 months)
| Date |
Name |
Role |
Type |
Shares |
Price |
Value |
| 2025-12-19 |
Bashan Dror |
President and CEO |
Informative Buy |
56,000 |
$1.81 |
$101.36K |
| 2025-11-18 |
Bar-shalev Amos |
Director |
Informative Sell |
168 |
$1.87 |
$314.16 |
| 2025-09-03 |
Elze Christian |
Director |
RSU Award |
7,500 |
- |
- |
| 2025-09-03 |
Ben Zvi Shmuel |
Director |
RSU Award |
7,500 |
- |
- |
| 2025-09-03 |
Forster Eliot |
Director |
RSU Award |
7,500 |
- |
- |
| 2025-09-03 |
Bashan Dror |
President and CEO |
RSU Award |
340,000 |
$1.64 |
$557.6K |
| 2025-09-03 |
Naos Yaron |
Sr. VP, Operations |
RSU Award |
50,000 |
$1.64 |
$82K |
| 2025-09-03 |
Schwartz Aharon |
Director |
RSU Award |
7,500 |
- |
- |
| 2025-09-03 |
Melincoff Gwen A |
Director |
RSU Award |
7,500 |
- |
- |
| 2025-09-03 |
Boudes Pol F |
Director |
RSU Award |
7,500 |
- |
- |
| 2025-09-03 |
Bar-shalev Amos |
Director |
RSU Award |
7,500 |
- |
- |
| 2025-08-24 |
Mamlok Gilad |
Sr. VP and CFO |
Unknown |
597,990 |
$1.45 |
$867.09K |
| 2025-06-10 |
Schwartz Aharon |
Director |
Informative Buy |
129,000 |
$1.60 |
$205.88K |
| 2025-06-26 |
Elze Christian |
Officer |
Unknown |
- |
- |
- |
